Sign up to save your podcasts
Or
Share Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors
Dr. Shuvro Roy and Dr. Alexander Gill discuss his paper "Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors."
Show reference:
https://www.aan.com/conferences-community/summer-conference/abstracts/
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Shuvro Roy and Dr. Alexander Gill discuss his paper "Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors."
Show reference:
https://www.aan.com/conferences-community/summer-conference/abstracts/
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
More shows like Neurology Minute
View all
JAMA Editors' Summary
130 Listeners
Neurology® Podcast
289 Listeners
NEJM This Week
324 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
493 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
87 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
185 Listeners
Navigating Neuropsychology
340 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
78 Listeners